Načítá se...
Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism
1. The effects of the angiotensin-converting-enzyme inhibitor (ACEI) ramiprilat, the angiotensin II type 1 receptor antagonist (AT(1)A) candesartan, and the combination of both drugs on infarct size (IS) resulting from regional myocardial ischaemia were studied in pigs. 2. Both ACEI and AT(1)A reduc...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2000
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1572300/ https://ncbi.nlm.nih.gov/pubmed/10960080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0703544 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|